These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10834047)

  • 1. Screening for lung cancer: can it be cost-effective?
    Miettinen OS
    CMAJ; 2000 May; 162(10):1431-6. PubMed ID: 10834047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection for lung cancer. New tools for casefinding.
    Lam S; Lam B; Petty TL
    Can Fam Physician; 2001 Mar; 47():537-44. PubMed ID: 11281087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada.
    Xie F; O'Reilly D; Ferrusi IL; Blackhouse G; Bowen JM; Tarride JE; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):317-23. PubMed ID: 19394572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of colorectal cancer.
    Winawer SJ
    Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for lung cancer--a review.
    Kuzniar T; Masters GA; Ray DW
    Med Sci Monit; 2004 Feb; 10(2):RA21-30. PubMed ID: 14737058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential impact of population-based colorectal cancer screening in Canada.
    Flanagan WM; Le Petit C; Berthelot JM; White KJ; Coombs BA; Jones-McLean E
    Chronic Dis Can; 2003; 24(4):81-8. PubMed ID: 14733756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis.
    Ginsberg GM; Edejer TT; Lauer JA; Sepulveda C
    Vaccine; 2009 Oct; 27(43):6060-79. PubMed ID: 19647813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for cancer with PET and PET/CT: potential and limitations.
    Schöder H; Gönen M
    J Nucl Med; 2007 Jan; 48 Suppl 1():4S-18S. PubMed ID: 17204716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing and testing a cost-assessment tool for cancer screening programs.
    Subramanian S; Ekwueme DU; Gardner JG; Trogdon J
    Am J Prev Med; 2009 Sep; 37(3):242-7. PubMed ID: 19666160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans.
    Wolf MS; Fitzner KA; Powell EF; McCaffrey KR; Pickard AS; McKoy JM; Lindenberg J; Schumock GT; Carson KR; Ferreira MR; Dolan NC; Bennett CL
    J Clin Oncol; 2005 Dec; 23(34):8877-83. PubMed ID: 16314648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for lung cancer: it's still not worthwhile.
    Lally J
    Del Med J; 1993 Apr; 65(4):273-4. PubMed ID: 8467935
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer screening in the USA.
    Smith RA
    J Med Screen; 2006; 13 Suppl 1():S48-53. PubMed ID: 17227643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health and economic benefits of well-designed evaluations: some lessons from evaluating neuroblastoma screening.
    Soderstrom L; Woods WG; Bernstein M; Robison LL; Tuchman M; Lemieux B
    J Natl Cancer Inst; 2005 Aug; 97(15):1118-24. PubMed ID: 16077069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety net: a cost-effective approach to improving breast and cervical cancer screening.
    Vogt TM; Glass A; Glasgow RE; La Chance PA; Lichtenstein E
    J Womens Health (Larchmt); 2003 Oct; 12(8):789-98. PubMed ID: 14588129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distorted spending priorities in Canada.
    Tyers GF
    CMAJ; 2000 May; 162(10):1402, 1404. PubMed ID: 10834040
    [No Abstract]   [Full Text] [Related]  

  • 19. Making decisions about screening for ovarian cancer. Mass screening may not prove to be sound public health policy.
    Bell R
    BMJ; 2000 Apr; 320(7239):940; author reply 940-1. PubMed ID: 10787261
    [No Abstract]   [Full Text] [Related]  

  • 20. Lung cancer screening as a predictor of future alternative payment models.
    Silva E
    J Am Coll Radiol; 2014 Nov; 11(11):1022. PubMed ID: 25278495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.